XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Equity (Tables)
 9 Months Ended
Apr. 02, 2022
Equity [Abstract]  
Schedule of impact on results of operations of recording stock-based compensation by function
The impact on our results of operations of recording stock-based compensation by function for the periods presented was as follows (in millions):
Three Months EndedNine Months Ended
April 2, 2022April 3, 2021April 2, 2022April 3, 2021
Cost of sales$5.4 $5.3 $15.2 $13.8 
Research and development5.4 5.3 15.8 14.8 
Selling, general and administrative12.5 14.5 44.4 40.1 
Total stock-based compensation$23.3 $25.1 $75.4 $68.7 
Schedule of income tax benefit associated with stock-based compensation
Total income tax benefit associated with stock-based compensation recognized in our condensed consolidated statements of operations during the years presented was as follows (in millions):
Three Months EndedNine Months Ended
April 2, 2022April 3, 2021April 2, 2022April 3, 2021
Income tax benefit associated with stock-based compensation$2.7 $3.4 $10.9 $12.2 
Schedule of awards activity
The following table summarizes our award activity for the nine months ended April 2, 2022 (in millions, except per share amounts):
Restricted Stock UnitsPerformance Stock Units
Number of SharesWeighted-Average Grant Date Fair Value per ShareNumber of SharesWeighted-Average Grant Date Fair Value per Share
Balance as of July 3, 20211.8 $76.02 0.3 $75.68 
Granted1.4 87.92 0.2 85.72 
Vested(0.9)73.71 (0.1)76.43 
Canceled(0.2)78.65 — 58.65 
Balance as of April 2, 20222.1 $84.70 0.4 $81.27 
Schedule of awards available for grant
A summary of awards available for grant is as follows (in millions):
Awards Available for Grant
Balance as of July 3, 20212.3 
   Authorized3.0 
Granted(1.6)
Canceled0.2 
Balance as of April 2, 20223.9